Antabuse is a medicine for adults who have chosen alcohol abstinence and can follow a structured treatment plan. Its active ingredient, disulfiram, creates an unpleasant reaction after alcohol exposure, helping reinforce the decision not to drink.
Antabuse is a disulfiram tablet used as part of treatment for alcohol dependence. The dose is stated on the pack — follow the leaflet. Disulfiram is an alcohol-sensitising medicine.
The dose of disulfiram is stated on the pack — follow the leaflet. Disulfiram is an alcohol-sensitising medicine, meaning it changes how the body processes alcohol rather than reducing intoxication or treating withdrawal symptoms.
The medicine is used after alcohol has cleared from the body. It works best when abstinence is a clear, agreed goal and when treatment includes counselling, behavioural support, or a supervised recovery programme.
Disulfiram does not remove cravings for everyone. Its main strength is creating a physical barrier against drinking, which can help people who respond well to a clear consequence.
Antabuse is taken by mouth as tablets. The dose is stated on the pack — follow the leaflet and use it only according to the prescribed regimen, which may be adjusted for treatment response, adverse effects, liver health, age, and concurrent medicines.
A clinician normally confirms that the person has not consumed alcohol for at least 12 hours before the first dose. Disulfiram’s enzyme-blocking effect can continue after the last tablet, so alcohol must also be avoided for up to 14 days after treatment stops [2].
Common administration principles include:
Alcohol is normally broken down in two stages. First, alcohol becomes acetaldehyde. Then an enzyme called aldehyde dehydrogenase converts acetaldehyde into acetate, which the body can process further.
Disulfiram blocks aldehyde dehydrogenase. If alcohol is consumed, acetaldehyde builds up rapidly and can trigger facial flushing, throbbing headache, nausea, vomiting, sweating, chest discomfort, palpitations, breathlessness, dizziness, and low blood pressure. Severe reactions can include collapse, abnormal heart rhythm, seizures, or myocardial infarction in vulnerable people [1].
The reaction is intentional, but it is not mild for every person. Antabuse is therefore a commitment medicine rather than a casual aid for cutting down.
Antabuse is intended for adults who have chosen alcohol abstinence and can follow a structured treatment plan. Its active ingredient, disulfiram, creates an unpleasant reaction after alcohol exposure, helping reinforce the decision not to drink.
Antabuse is one of several medicines used in alcohol-dependence treatment. The best option depends on the person’s drinking pattern, medical history, liver and kidney function, treatment goals, and ability to maintain abstinence.
| Medicine | Main approach | Practical distinction |
|---|---|---|
| Disulfiram | Causes acetaldehyde accumulation after alcohol exposure | Best suited to a firm abstinence goal and reliable daily adherence |
| Naltrexone | Reduces opioid-receptor reward from alcohol | May help reduce heavy-drinking urges; unsuitable with opioid use or acute hepatitis |
| Acamprosate | Modulates glutamate and GABA signalling during abstinence | Often used to support abstinence after detoxification; requires renal assessment |
Disulfiram is distinct because it does not primarily work by reducing the rewarding effect of alcohol. It creates a deterrent reaction. This can be useful for people who have predictable high-risk situations, such as weekends, business travel, or social gatherings.
Naltrexone may be preferred when reducing heavy drinking is the first goal. Acamprosate may be a better fit when abstinence has already been established and maintaining it is the priority. A 2014 meta-analysis indexed in PubMed found that supervised disulfiram treatment produced better outcomes than several comparison approaches, while unsupervised treatment showed less consistent benefit [3].
It is also not appropriate for people with:
Extra caution is needed with epilepsy, diabetes, hypothyroidism, kidney disease, brain injury, liver impairment, and a history of severe depression. Pregnancy and breastfeeding require an individual medical assessment because safety data are limited.
Disulfiram can interact with several medicines. It may increase the effect of warfarin and raise bleeding risk. It can increase phenytoin concentrations and may affect the metabolism of diazepam, chlordiazepoxide, and some tricyclic antidepressants. Isoniazid combined with disulfiram has been associated with behavioural and coordination changes.
Antabuse is not for you if you are unable to avoid alcohol completely, including alcohol-containing medicines and products.
Some people tolerate Antabuse without major difficulty. Others find adverse effects limit treatment. Drowsiness, fatigue, headache, metallic or garlic-like taste, acne-like skin eruptions, reduced libido, and stomach upset may occur, especially early in treatment.
A metallic taste is a small detail that patients often mention during the first days. It can be annoying, yet it does not automatically mean the medicine must be stopped.
More serious adverse effects need prompt medical assessment:
The FDA prescribing information describes hepatitis, including rare severe and fatal cases, as an important risk. Liver-function testing is commonly arranged before treatment and during early therapy, often around 10 to 14 days after initiation when clinically appropriate [1].
Physicians also look beyond the number of alcohol-free days. They assess sleep, mood, anxiety, liver symptoms, medication interactions, and situations that create relapse pressure. Alcohol dependence commonly coexists with depression, trauma, chronic pain, or anxiety, so a single tablet is rarely the whole treatment plan.
The World Health Organization recognises alcohol dependence as a health condition that benefits from combined medical, psychological, and social support rather than willpower alone [4].
Alcohol should be avoided for up to 14 days after the final dose because disulfiram’s effect on aldehyde dehydrogenase can persist. A person may still experience flushing, vomiting, low blood pressure, or a more serious reaction during this period. The FDA prescribing information published in 2012 describes this prolonged alcohol sensitivity. Alcohol-containing liquid medicines and food preparations also require attention. A pharmacist can help identify hidden alcohol in medicines and personal-care products.
Antabuse does not treat acute alcohol withdrawal. Symptoms such as shaking, sweating, agitation, hallucinations, confusion, or seizures can require urgent medical management with other medicines and monitoring. NICE guidance, first issued in 2011 and updated in 2017, separates medically assisted withdrawal from relapse-prevention treatment. Disulfiram is considered after the person is alcohol-free and clinically stable.
Antabuse mainly creates a deterrent to drinking rather than directly suppressing cravings. Some people report fewer drinking episodes because the anticipated reaction interrupts impulsive decisions. The 2014 PLOS ONE meta-analysis found that outcomes were stronger when disulfiram use was supervised. Persistent cravings can still need behavioural therapy or another medication strategy.
Disulfiram can enhance warfarin’s anticoagulant effect and may increase bleeding risk. A prescriber may need to adjust warfarin treatment and arrange closer INR monitoring. The FDA’s 2012 Antabuse prescribing information lists this as a clinically relevant interaction. Unusual bruising, nosebleeds, black stools, or prolonged bleeding require prompt assessment.
Disulfiram can rarely cause serious liver injury, including hepatitis. Liver-function tests help identify changes before symptoms become severe, especially during the first weeks of treatment. The FDA documentation from 2012 advises baseline and follow-up liver monitoring when clinically indicated. Jaundice, dark urine, itching, abdominal pain, or persistent nausea should not be ignored.
No. It is best suited to adults who can commit to complete alcohol avoidance and who do not have contraindications such as severe heart disease, psychosis, or a relevant medicine interaction. The WHO’s 2018 alcohol report emphasises that treatment should be matched to the person’s health needs and recovery setting. Some people may benefit more from naltrexone, acamprosate, supervised withdrawal care, or psychological treatment.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
I used it after detoxification because evenings were my weak point. The first week I had a headache and a strange metallic taste, then those settled. Knowing I could not drink made it easier to leave work gatherings early.
My partner helped me keep a morning routine, which made a bigger difference than I expected. I had to replace an alcohol mouthwash and ask about a cough syrup before using it. I stayed alcohol-free during the three months.
I felt sleepy in the afternoon and stopped taking it for two days without thinking about the lingering effect. I did not drink, but it made me realise I needed clearer advice and regular follow-up.
It was useful as a barrier, not as a cure for stress. I still had cravings after arguments at home, so counselling was the part that helped me understand why I drank.
